In vitro malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene

Toxicology in Vitro

Volumn 26, Issue 2, 2012, Pages 362-368

  Zhao, Peng ^a   Fu, Juanling ^a   Yao, Biyun ^a   Song, Yanchao ^a   Mi, Lan ^a   Li, Zhenning ^a   Shang, Lanqin ^a   Hao, Weidong ^a   Zhou, Zongcan ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

16HBE cells; Benzo(a)pyrene; Cell migration; Malignant transformation; P Akt (Ser473); P53

Indexed keywords

BENZO[A]PYRENE; BIOLOGICAL MARKER; CYCLINE; PROTEIN KINASE B; PROTEIN P53; TUMOR PROTEIN D52; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL MIGRATION; CELL NUCLEUS; CHEMICAL CARCINOGENESIS; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG METASTASIS; MALIGNANT TRANSFORMATION; MITOSIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; BENZO(A)PYRENE; BRONCHI; CARCINOGENS; CELL LINE; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR BURDEN; TUMOR SUPPRESSOR PROTEIN P53;

MUS MUSCULUS;

EID: 84862802546     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.12.013     Document Type: Article

References (31)

1. Altomare D.A., Testa J.R. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005, 24:7455-7464.
2. Anumanthan G., Halder S.K., Osada H., Takahashi T., Massion P.P., Carbone D.P., Datta P.K. Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells. Br. J. Cancer 2005, 93:1157-1167.
3. Benbrahim-Tallaa L., Tokar E.J., Diwan B.A., Dill A.L., Coppin J.F., Waalkes M.P. Cadmium malignantly transforms normal human breast epithelial cells into a basal-like phenotype. Environ. Health Perspect. 2009, 117:1847-1852.
4. Edwards B.K., Brown M.L., Wingo P.A., Howe H.L., Ward E., Ries L.A., Schrag D., Jamison P.M., Jemal A., Wu X.C., Friedman C., Harlan L., Warren J., Anderson R.N., Pickle L.W. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J. Natl. Cancer Inst. 2005, 97:1407-1427.
5. Friesen M.C., Demers P.A., Spinelli J.J., Lorenzi M.F., Le N.D. Comparison of two indices of exposure to polycyclic aromatic hydrocarbons in a retrospective aluminium smelter cohort. Occup. Environ. Med. 2007, 64:273-278.
6. Gao Z., Jin J., Yang J., Yu Y. Zinc finger proteins and other transcription regulators as response proteins in benzo[a]pyrene exposed cells. Mutat. Res. 2004, 550:11-24.
7. Goldstein I., Marcel V., Olivier M., Oren M., Rotter V., Hainaut P. Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Ther. 2011, 18:2-11.
8. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
9. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
10. Hers I., Vincent E.E., Tavaré J.M. Akt signalling in health and disease. Cell Signal. 2011, 23:1515-1527.
11. Huang J., Lin J., McCormick J.J. Studies of multistep process of environmental carcinogenesis using in vitro model for human fibroblast transformation. Carcin Teratogen Mut 1998, 10:336-341.
12. International Agency for Research on Cancer, 1998. IARC monographs on the evalution of the carcinogenic risk of chemicals to humans; polynuclear aromatic compounds, part 1: chemical, environmental and experimental data. World Health Organization. Lyon, France.
13. Jiang Y., Wu Y., Greenlee A.R., Wu J., Han Z., Li X., Zhao Y. MiR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. Toxicol. Sci. 2011, 119:50-60.
14. Jiang Y.G., Chen J.K., Chen X.M. Malignant transformation of human bronchial epithelial cells induced by benzo(a)pyrene metabolite dihydroxyepoxy benzo pyrene. Wei Sheng Yan Jiu 2001, 30:129-131.
15. Kikuchi T., Carbone D.P. Proteomics analysis in lung cancer: challenges and opportunities. Respirology 2007, 12:22-28.
16. Lewis J.D., Payton L.A., Whitford J.G., Byrne J.A., Smith D.I., Yang L., Bright R.K. Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52. Mol. Cancer Res. 2007, 5:133-144.
17. Mende I., Malstrom S., Tsichlis P.N., Vogt P.K., Aoki M. Oncogenic transformation induced by membrane-targeted Akt2 and Akt3. Oncogene 2001, 20:4419-4423.
18. Mori I. Cancer mortality among man-made graphite electrode manufacturing workers: results of a 38 year follow up. Occup. Environ. Med. 2002, 59:473-480.
19. Nicholson K.M., Anderson N.G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002, 14:381-395.
20. Oh S., Im H., Oh E., Lee J., Khim J.Y., Mun J., Kim Y., Lee E., Kim J., Sul D. Effects of benzo(a)pyrene on protein expression in Jurkat T-cells. Proteomics 2004, 4:3514-3526.
21. Qi Y., Zhao P., Fu J., Yao B., Yuan Z., Hu E., Zhou Z. Claspin is involved in S-phase checkpoint induced by benzo(a)pyrene in 16HBE cells. Toxicol. In Vitro 2009, 23:880-886.
22. Rodrigues C.F., Urbano A.M., Matoso E., Carreira I., Almeida A., Santos P., Botelho F., Carvalho L., Alves M., Monteiro C., Costa A.N., Moreno V., Alpoim M.C. Human bronchial epithelial cells malignantly transformed by hexavalent chromium exhibit an aneuploid phenotype but no microsatellite instability. Mutat. Res. 2009, 670:42-52.
23. Shen W., Liu H., Yu Y. Proteomic analysis of cellular responses to different concentrations of anti-benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide in human amniotic epithelial FL cells. J. Proteome Res. 2007, 6:4737-4748.
24. Smith L.E., Denissenko M.F., Bennett W.P., Li H., Amin S., Tang M., Pfeifer G.P. Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 2000, 92:803-811.
25. Tsai K.S., Yang R.S., Liu S.H. Benzo[a]pyrene regulates osteoblast proliferation through an estrogen receptor-related cyclooxygenase-2 pathway. Chem. Res. Toxicol. 2004, 17:679-684.
26. Ummanni R., Teller S., Junker H., Zimmermann U., Venz S., Scharf C., Giebel J., Walther R. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells. FEBS J. 2008, 275:5703-5713.
27. US CDC/ATSDR, 1995. Toxicological profile for polycyclic aromatic hydrocarbons. http://www.atsdr.cdc.gov/toxprofiles/tp69.pdf.
28. Yao B., Fu J., Hu E., Qi Y., Zhou Z. The Cdc25A is involved in S-phase checkpoint induced by benzo(a)pyrene. Toxicology 2007, 237:210-217.
29. Zhang L., Huang H., Deng L., Chu M., Xu L., Fu J., Zhu Y., Zhang X., Liu S., Zhou Z., Wang Y. TPX2 in malignantly transformed human bronchial epithelial cells by anti-benzo[a]pyrene-7,8-diol-9,10-epoxide. Toxicology 2008, 252:49-55.
30. Zhao P., Zhong W., Ying X., Yao B., Yuan Z., Fu J., Zhou Z. Comparative proteomic analysis of anti-Benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide transformed and normal human bronchial epithelial G0/G1 cells. Chem. Biol. Interact. 2010, 186:166-173.
31. Zhao P., Zhong W., Ying X., Yuan Z., Fu J., Zhou Z. Manganese chloride-induced G0/G1 and S phase arrest in A549 cells. Toxicology 2008, 250:39-46.